CCL2 and prostate cancer: Moreover, within a model of bone metastasis established by intratibia injection of prostate cancer cells, a paracrine interaction between the cancer cells and osteoblasts exists where prostate cancer-derived PTHrP induces CCL2 secretion in the osteoblasts.